New study finds SARSCoV-2 antibody tests risky for predicting individual immunity

Washington: Antibody tests for SARSCoV-2, the virus causes COVID-19, are useful for population-level assessments, but risky for predicting individual immunity, according to a new study published in Science Immunology.

Serological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 response efforts.

However, the required performance characteristics of antibody tests will critically depend on the use case on individual-level and population-level, according to the joint study by researchers from University of Utah Health, Johns Hopkins Bloomberg School of Public Health, Harvard School of Public Health, University of California, San Francisco and Pennsylvania State University.